Canadian giant Canopy Growth reported a staggering C$1.2B loss, though almost all of it was related to a one-time charge. ��Jesse has all the details at WW Canada.
CNBC
- Canadian MED company Tilray reported a loss of $17.9M, more than analysts anticipated. While cannabis investors are increasingly concerned on profitability, Tilray CEO Brendan Kennedy said, “You’d be constraining yourself if you were focused on profitability at this point.”
Bloomberg - One analyst called Tilray’s quarter a “disaster” and advised avoiding the stock “until industry rationalization occurs.”
Seeking Alpha - MarketWatch calls unprofitable early acquisitions a “time bomb” on many of the largest Canadian companies’ balance sheets.
- At New Cannabis Ventures, Alan Brochstein explains why he’s still not a fan of cannabis exchange traded funds (ETFs).
